Literature DB >> 14353090

[The effects of ribonuclease on cells of Ehrlich carcinoma].

L LEDOUX, E BALTUS.   

Abstract

Entities:  

Keywords:  NEOPLASMS/metabolism in; NUCLEASES; NUCLEIC ACIDS/metabolism

Mesh:

Substances:

Year:  1954        PMID: 14353090     DOI: 10.1007/bf02166182

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  1 in total

1.  [The active groups of ribonuclease. II. Oxidation-reduction].

Authors:  L LEDOUX
Journal:  Biochim Biophys Acta       Date:  1954-01
  1 in total
  12 in total

Review 1.  Cancer chemotherapy--ribonucleases to the rescue.

Authors:  P A Leland; R T Raines
Journal:  Chem Biol       Date:  2001-05

2.  [COMPARATIVE STUDY OF THE EFFECT OF RIBONUCLEASE ON HELA AND FL CELL CULTURES].

Authors:  N S FOTAKIS; A STAMMLER
Journal:  Arch Gesamte Virusforsch       Date:  1963-10-07

3.  The nature of the fluctuating ribonucleic acid in Escherichia coli.

Authors:  H E WADE; D M MORGAN
Journal:  Biochem J       Date:  1957-02       Impact factor: 3.857

4.  [Not Available].

Authors:  J Brachet; N Six
Journal:  Planta       Date:  1966-09       Impact factor: 4.116

5.  A Human Ribonuclease Variant and ERK-Pathway Inhibitors Exhibit Highly Synergistic Toxicity for Cancer Cells.

Authors:  Trish T Hoang; I Caglar Tanrikulu; Quinn A Vatland; Trieu M Hoang; Ronald T Raines
Journal:  Mol Cancer Ther       Date:  2018-10-03       Impact factor: 6.261

Review 6.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

Review 7.  Ribonucleases as potential modalities in anticancer therapy.

Authors:  Wojciech Ardelt; Barbara Ardelt; Zbigniew Darzynkiewicz
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

Review 8.  Discovery of antitumor effects of leczymes.

Authors:  Takeo Tatsuta; Masahiro Hosono
Journal:  Glycoconj J       Date:  2022-01-23       Impact factor: 2.916

9.  Structure analysis of group I plant nucleases.

Authors:  Jan Dohnálek; Tomáš Koval'; Petra Lipovová; Tomáš Podzimek; Jaroslav Matoušek
Journal:  J Synchrotron Radiat       Date:  2010-11-05       Impact factor: 2.616

10.  Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma.

Authors:  Camillo Porta; Chiara Paglino; Luciano Mutti
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.